Viridicatumtoxin B, a new anti-MRSA agent from Penicillium sp. FR11

Chang-Ji Zheng,Hyung-Eun Yu,Eun-Hee Kim,Won-Gon Kim
DOI: https://doi.org/10.1038/ja.2008.84
2008-10-01
The Journal of Antibiotics
Abstract:A new tetracycline-type antibiotic named viridicatumtoxin B along with the known compound viridicatumtoxin has been isolated from the mycelium of liquid fermentation cultures of Penicillium sp. FR11. The structure of viridicatumtoxin B was determined on the basis of MS and NMR data. Viridicatumtoxin B inhibited the growth of Staphylococcus aureus including methicillinresistant S. aureus and quinolone-resistant S. aureus with MIC (μg/ml) of 0.5, which is similar with that of vancomycin, but 8∼64 times higher activity than that of tetracycline.
What problem does this paper attempt to address?